XML 27 R16.htm IDEA: XBRL DOCUMENT v3.23.2
Earnings Per Share
6 Months Ended
Jun. 30, 2023
Earnings Per Share [Abstract]  
Earnings Per Share Earnings Per Share
The following table summarizes the Company’s computation of basic and diluted earnings per share (EPS) for the three and six months ended June 30, 2023 and 2022 (amounts in thousands except per share information):
 Three Months Ended June 30, 2023Six Months Ended June 30, 2023
 Income
(numerator)
Shares
(denominator)
Per Share
Amount
Income
(numerator)
Shares
(denominator)
Per Share
Amount
Basic EPS:
Net income$13,600 $71,257 
Less: preferred dividend requirements(6,040)(12,073)
Net income available to common shareholders$7,560 75,297 $0.10 $59,184 75,191 $0.79 
Diluted EPS:
Net income available to common shareholders$7,560 75,297 $59,184 75,191 
Effect of dilutive securities:
Performance shares— 418 — 380 
Net income available to common shareholders$7,560 75,715 $0.10 $59,184 75,571 $0.78 
 Three Months Ended June 30, 2022Six Months Ended June 30, 2022
 Income
(numerator)
Shares
(denominator)
Per Share
Amount
Income
(numerator)
Shares
(denominator)
Per Share
Amount
Basic EPS:
Net income$40,909 $83,101 
Less: preferred dividend requirements (6,033)(12,066)
Net income available to common shareholders$34,876 74,986 $0.47 $71,035 74,915 $0.95 
Diluted EPS:
Net income available to common shareholders$34,876 74,986 $71,035 74,915 
Effect of dilutive securities:
Share options and performance shares— 248 — 227 
Net income available to common shareholders$34,876 75,234 $0.46 $71,035 75,142 $0.95 

The effect of the potential common shares from the conversion of the Company’s convertible preferred shares and from the exercise of share options are included in diluted earnings per share if the effect is dilutive. Potential common shares from the performance shares are included in diluted earnings per share upon the satisfaction of certain performance and market conditions. These conditions are evaluated at each reporting period and if the conditions have been satisfied during the reporting period, the number of contingently issuable shares are included in the computation of diluted earnings per share.

The following shares have been excluded from the calculation of diluted earnings per share, either because they are anti-dilutive or, in the case of contingently issuable performance shares, are not probable of issuance:
The additional 2.3 million and 2.2 million common shares that would result from the conversion of the Company’s 5.75% Series C cumulative convertible preferred shares and the corresponding add-back of the preferred dividends declared on those shares for the three and six months ended June 30, 2023 and 2022, respectively.
The additional 1.7 million common shares that would result from the conversion of the Company’s 9.0% Series E cumulative convertible preferred shares and the corresponding add-back of the preferred dividends declared on those shares for both the three and six months ended June 30, 2023 and 2022.
Outstanding options to purchase 83 thousand and 89 thousand common shares at per share prices ranging from $44.44 to $76.63 for the three and six months ended June 30, 2023 and 2022, respectively.
•The effect of 56 thousand contingently issuable performance shares granted during 2020 for the three and six months ended June 30, 2022.